Lobbying Information
Subject Matters
- Budget
- Economic Development
- Health
- Industry
- Intellectual Property
- International Trade
- Taxation and Finance
Subject Matter Details
Policies or Program
- Canada’s Innovation and Skills Plan, led by Innovation, Science and Economic Development Canada, with respect to ensuring that the life sciences sector is a major focus of the government’s post-COVID recovery plan
- Engagement with federal officials regarding Health Canada’s plans for the creation of a national strategy for rare diseases, national pharmacare and the Canada Drug Agency
- Engagement with federal officials regarding Innovation, Science and Economic Development Canada’s plans for the creation of new biomanufacturing capacity for Canada
Policies or Program, Regulation
- Guidelines, policies and programs related to regulatory and reporting functions of the Patented Medicine Prices Review Board
Regulation
- Amendments to the Patented Medicines Regulations published in Canada Gazette, Part II on August 21, 2019, June 10, 2020 and January 21, 2021
Communication Techniques
-
Written communication
-
Oral communication
-
Grass-roots communication
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Government Institutions
-
Finance Canada (FIN)
-
House of Commons
-
Innovation, Science and Economic Development Canada (ISED)
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Privy Council Office (PCO)
-
Senate of Canada
-
Treasury Board Of Canada Secretariat (TBS)
Client Details
Government funding
No government funding was received during the last completed financial year.
Client Contact Information
Address:
5401 route Trans Canadienne
St-Laurent, QC H4S 1Z1
Canada
Telephone number:
514-906-9700
Client representative
Kevin Bernard, Manager, Government Affairs & Policy
Parent Company Information
AbbVie Corporation is not a subsidiary of any other parent companies.
Coalition Members Information
AbbVie Corporation is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of AbbVie Corporation are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
AbbVie Corporation does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Lobbyist Details
WILLIAM DEMPSTER
|
Public offices held
Business address:
150 Metcalfe Street
Suite 604
OTTAWA, ON K2P 1P1
Canada
Telephone number:
613-614-0283
Fax number:
613-249-3645
Consultant Firm and Address
Firm:
3Sixty Public Affairs Inc. / 3Sixty Public Affairs Inc.
Address:
150 Metcalfe Street
Suite 604
Ottawa, ON K2P 1P1
Canada
Telephone number:
343-961-9715
